Sreela & Sundaran Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 27.37%
(FY 2023)
- Profit 13.37%
(FY 2023)
- Ebitda 22.16%
(FY 2023)
- Net Worth 1199.04%
(FY 2023)
- Total Assets 22.23%
(FY 2023)
About Sreela & Sundaran Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thampu Sundaran, Ajish Prasanna, Lekshmi Sundaran, and One other member serve as directors at the Company.
- CIN/LLPIN
U85200KL2018PTC054324
- Company No.
054324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kollam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sreela & Sundaran Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thampu Sundaran  | Director | 13-Aug-2018 | Current |
| Ajish Prasanna | Director | 13-Aug-2018 | Current |
| Lekshmi Sundaran | Director | 13-Aug-2018 | Current |
| Sreela Yesodharan | Director | 13-Aug-2018 | Current |
Financial Performance of Sreela & Sundaran Healthcare.
Sreela & Sundaran Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.37% increase. The company also saw a substantial improvement in profitability, with a 13.37% increase in profit. The company's net worth Soared by an impressive increase of 1199.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreela & Sundaran Healthcare?
In 2023, Sreela & Sundaran Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sreelekshmi Cashew Enterprises Private LimitedActive 5 years 4 months
Sreela Yesodharan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sreela & Sundaran Healthcare?
Unlock and access historical data on people associated with Sreela & Sundaran Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreela & Sundaran Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreela & Sundaran Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
